Plain-English translation of NCT06266338 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether two medications called and work better together to treat cervical cancer that has spread to other parts of the body or has returned after earlier treatment. helps your immune system fight cancer cells, while slows cancer growth. The researchers want to see if using both medications at the same time improves outcomes for women with advanced cervical cancer.
Cervical cancer that has spread or come back is difficult to treat, and current options don't work well enough for all patients. This trial exists to find out whether combining these two different types of medication—one that boosts immunity and one that blocks cancer growth—might give patients better results and longer survival.
You likely qualify if…
You likely don't qualify if…
You would receive an injection of one medication every 3 weeks and take a daily pill of the other medication. This combination continues for up to 2 years (about 35 injections). If your cancer progresses after completing 2 years of treatment, you may be able to continue for up to 1 additional year. You'll have regular hospital or clinic visits for blood tests, scans, and check-ups to monitor how well the treatment is working and manage any side effects.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
United States